Literature DB >> 8160190

All in the family: the toxic activity of pore-forming colicins.

J H Lakey1, F G van der Goot, F Pattus.   

Abstract

Colicins are unusual bacterial toxins because they are directed against close relatives of the producing strain. They kill their targets in one of three distinct ways; via a ribonuclease or deoxyribonuclease activity or by forming pores in the target cell's membrane. This review deals with the steps involved in pore-forming colicin activity including, initial synthesis of the toxin, toxin release, receptor binding, translocation across the periplasm and pore formation in the cytoplasmic membrane. Special reference is made to the role of colicin in vivo, the structural changes occurring during pore formation and the role of the immunity protein.

Mesh:

Substances:

Year:  1994        PMID: 8160190     DOI: 10.1016/0300-483x(94)90156-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  18 in total

Review 1.  Pore-forming toxins: ancient, but never really out of fashion.

Authors:  Matteo Dal Peraro; F Gisou van der Goot
Journal:  Nat Rev Microbiol       Date:  2015-12-07       Impact factor: 60.633

2.  Biophysical basis of the promiscuous binding of B-cell lymphoma protein 2 apoptotic repressor to BH3 ligands.

Authors:  Vikas Bhat; Max B Olenick; Brett J Schuchardt; David C Mikles; Caleb B McDonald; Amjad Farooq
Journal:  J Mol Recognit       Date:  2013-10       Impact factor: 2.137

3.  The tip of the hydrophobic hairpin of colicin U is dispensable for colicin U activity but is important for interaction with the immunity protein.

Authors:  H Pilsl; D Smajs; V Braun
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

4.  Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells.

Authors:  A Valeva; I Walev; M Pinkernell; B Walker; H Bayley; M Palmer; S Bhakdi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  The channel domain of colicin A is inhibited by its immunity protein through direct interaction in the Escherichia coli inner membrane.

Authors:  D Espesset; D Duché; D Baty; V Géli
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

6.  Molecular determinants of the binding specificity of BH3 ligands to BclXL apoptotic repressor.

Authors:  Vikas Bhat; Max B Olenick; Brett J Schuchardt; David C Mikles; Caleb B McDonald; Amjad Farooq
Journal:  Biopolymers       Date:  2014-06       Impact factor: 2.505

7.  Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism.

Authors:  Guruvasuthevan R Thuduppathy; Jeffrey W Craig; Victoria Kholodenko; Arne Schon; R Blake Hill
Journal:  J Mol Biol       Date:  2006-04-06       Impact factor: 5.469

8.  On the nature of the unfolded intermediate in the in vitro transition of the colicin E1 channel domain from the aqueous to the membrane phase.

Authors:  S L Schendel; W A Cramer
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

9.  Heat-induced fibrillation of BclXL apoptotic repressor.

Authors:  Vikas Bhat; Max B Olenick; Brett J Schuchardt; David C Mikles; Brian J Deegan; Caleb B McDonald; Kenneth L Seldeen; Dmitry Kurouski; Mohd Hafeez Faridi; Mohammed M Shareef; Vineet Gupta; Igor K Lednev; Amjad Farooq
Journal:  Biophys Chem       Date:  2013-05-07       Impact factor: 2.352

10.  Acidic pH promotes oligomerization and membrane insertion of the BclXL apoptotic repressor.

Authors:  Vikas Bhat; Dmitry Kurouski; Max B Olenick; Caleb B McDonald; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Igor K Lednev; Amjad Farooq
Journal:  Arch Biochem Biophys       Date:  2012-08-30       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.